Immune- and inflammation-related targets

The term 'Immune- and inflammation-related targets' refers to a broad functional category of biological molecules rather than a single, specific therapeutic target. This classification encompasses a wide variety of proteins, including cytokines, cell surface receptors, and intracellular signaling enzymes that regulate the body's immune response and inflammatory pathways (O'Shea et al., 2013, Nature Reviews Drug Discovery). These targets are fundamental to the pathophysiology of diverse diseases such as rheumatoid arthritis, psoriasis, and chronic obstructive pulmonary disease, where they drive the inflammatory cascade (Newton & Dixit, 2012, Cold Spring Harbor Perspectives in Biology). Therapeutic intervention in this space involves a range of modalities, from monoclonal antibodies that sequester pro-inflammatory ligands to small molecule inhibitors of signaling kinases. Because this entry represents a heterogeneous group of molecules, it does not possess a unique canonical structure or a single mechanism of action. For drug discovery and clinical applications, specific targets within this category must be identified and characterized individually to ensure therapeutic efficacy and safety.

Other names

Immunomodulatory targetsInflammatory targetsImmune system targets

Not applicable; this is a broad category of targets rather than a single molecular entity.